Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Glycogen Synthase Kinase 3β Regulates Cell Death Induced by Synthetic Triterpenoids
2008
The clinical symptoms of Parkinson's disease
2016 Standout
Naringenin‐Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways
2016
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
2016 Standout
Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review
2014
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen
2013
Meta‐analysis showing the beneficial effect of α‐blockers on ureteric stent discomfort
2011
Mitogen- and Stress-Activated Kinase 1–Mediated Histone H3 Phosphorylation Is Crucial for Cell Transformation
2008
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
2021 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Erectile Dysfunction in Young Surgically Treated Patients With Lumbar Spine Disease
2011
A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysis
2012
Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
2018
Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions
2010
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Good quality white‐light transurethral resection of bladder tumours (GQ‐WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non‐muscle‐invasive bladder cancer: validation across time and place and recommendation for benchmarking
2011
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Effect of Supine vs Prone Position on Outcomes of Percutaneous Nephrolithotomy in Staghorn Calculi: Results From the Clinical Research Office of the Endourology Society Study
2013
Parkinson's disease: clinical features and diagnosis
2008 Standout
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Systematic Review of Complications of Prostate Biopsy
2013
Triterpenoids as new promising anticancer drugs
2009 Standout
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Kidney stones
2016
Hepatocellular carcinoma
2021 Standout
Impact of the Use of Bowel for Urinary Diversion on Perioperative Complications and 90-Day Mortality in Patients Aged 75 Years or Older
2015
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells
2011
Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
2011
2007 Guideline for the Management of Ureteral Calculi
2007 Standout
Multitargeted therapy of cancer by green tea polyphenols
2008
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)
2015
The basic biochemistry and molecular events of hormone therapy
2007
Extracellular matrix structure
2015 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review
2005
The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016
2016
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
2009 Standout
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
2010
Satraplatin: leading the new generation of oral platinum agents
2009
Urothelial carcinoma management in elderly or unfit patients
2016
Comparison of Ileal Conduit and Transureteroureterostomy with Ureterocutaneostomy Urinary Diversion
2006
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Prevention of retrograde stone migration during ureteroscopy
2006
EAU Guidelines on Interventional Treatment for Urolithiasis
2015 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Importance of Retroperitoneal Ureteric Evaluation in Cases of Deep Infiltrating Endometriosis
2008
Clinically Insignificant Residual Fragments: An Acceptable Term in the Computed Tomography Era?
2013
Carbonic Anhydrase IX: Regulation and Role in Cancer
2013
MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
2012
Prone versus Modified Supine Position in Percutaneous Nephrolithotomy: a Prospective Randomized Study
2013
Renal cell carcinoma
2017 Standout
Photodynamic diagnostic ureterorenoscopy: A valuable tool in the detection of upper urinary tract tumour
2015
Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience
2009
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo
2015
Perineural invasion in cancer
2009 Standout
Effects of α-Blockers, Antimuscarinics, or Combination Therapy in Relieving Ureteral Stent-Related Symptoms: A Meta-Analysis
2014
Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
2011
Nonmotor symptoms of Parkinson’s disease
2006
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy
2016
The difficult ureter: what is the incidence of pre-stenting?
2010
Copper-Catalyzed Synthesis of Mixed Alkyl Aryl Phosphonates
2014 StandoutNobel
Non-motor Symptoms of Parkinson's Disease
2007
Prospective Evaluation and Classification of Ureteral Wall Injuries Resulting from Insertion of a Ureteral Access Sheath During Retrograde Intrarenal Surgery
2012 Standout
Combination therapy in combating cancer
2017 Standout
The Therapeutic Potential of Naringenin: A Review of Clinical Trials
2019 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
2019
Is There a Role for α-Blockers in Ureteral Stent Related Symptoms? A Systematic Review and Meta-Analysis
2011
Bladder, Bowel, and Sexual Dysfunction in Parkinson's Disease
2011
Kidney Stone Disease: An Update on Current Concepts
2018 Standout
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II
2016 Standout
The CROES Percutaneous Nephrolithotomy Global Study: The Influence of Body Mass Index on Outcome
2012
Works of Athanasios Papatsoris being referenced
Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
2018
Expression of ERβ and Its Co-Regulators p300 and NCoR in Human Transitional Cell Bladder Cancer
2011
Is there a role for alpha1-blockers in treating double-J stent-related symptoms?
2006
Manipulation of the nerve growth factor network in prostate cancer
2007
Can prostate biopsies affect erectile function?
2006
Urinary diversion in high-risk elderly patients: Modified cutaneous ureterostomy or ileal conduit?
2005
Endometriosis of the urinary tract in women of reproductive age
2006
Matrix metalloproteinase inhibitors as anticancer agents
2007
Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)
2015
Novel insights into the implication of the IGF-1 network in prostate cancer
2005
Two Cases of Acute Polyarthritis Secondary to Intravesical BCG Adjuvant Therapy for Superficial Bladder Cancer
2002
Prognostic Significance of Cytoreductive Nephrectomy in Patients With Synchronous Metastases From Renal Cell Carcinoma Treated With First-Line Sunitinib: A European Multiinstitutional Study
2014
Use of External Ureteral Catheters and Internal Double J Stents in a Modified Ileal Neobladder for Continent Diversion: A Comparative Analysis
2005
Erectile dysfunction in Parkinson’s disease
2006
Novel therapeutics in metastatic bladder cancer
2008
Molecular ‘palpation’ of BPH: a tale of MAPK signalling?
2001
Novel Biological Agents for the Treatment of Hormone-Refractory Prostate Cancer (HRPC)
2005
Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia
2006
Prevention of retrograde calculus migration with the Stone Cone
2004
Supine percutaneous nephrolithotomy (PCNL): ‘in vogue’ but in which position?
2012
The New Digital Flexible Ureteroscopes: ‘Size Does Matter’ – Increased Ureteric Access Sheath Use!
2012
Inversion, Hydration and Diuresis during Extracorporeal Shock Wave Lithotripsy: Does It Improve the Stone-Free Rate for Lower Pole Stone Clearance?
2009
Tamsulosin versus transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic hyperplasia
2011
Treatment of impacted lower third ureteral stones with the use of the ureteral access sheath
2006
Simultaneous Anterograde and Retrograde Endourologic Access: “The Barts Technique”
2008
Diagnosis and Management of Postpercutaneous Nephrolithotomy Residual Stone Fragments
2009
Percutaneous Endourologic Procedures in High-Risk Patients in the Lateral Decubitus Position Under Regional Anesthesia
2009
Hypertension, Antihypertensive Therapy, and Erectile Dysfunction
2006
76 ALFUZOSIN VS TAMSULOSIN IN TREATING DOUBLE-J SENT RELATED MORBIDITY; A PROSPECTIVE COMPARATIVE STUDY
2007
Novel technologies in flexible ureterorenoscopy
2011
The novel prostate cancer antigen 3 (PCA3) biomarker
2010
The power and promise of “rewiring” the mitogen-activated protein kinase network in prostate cancer therapeutics
2007
The role of the cell adhesion molecules (integrins / cadherins) in prostate cancer
2011
DOES THE MANAGEMENT OF BLADDER PERFORATION DURING TRANSURETHRAL RESECTION OF SUPERFICIAL BLADDER TUMORS PREDISPOSE TO EXTRAVESICAL TUMOR RECURRENCE?
2005